BridgeBio Pharma, Inc. (BBIO)
NASDAQ · Healthcare
BridgeBio Pharma, Inc. Cash on Hand 2019–2025
BridgeBio Pharma, Inc. annual/quarterly cash on hand history from 2019 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- BridgeBio Pharma, Inc. cash on hand for the quarter ending December 31, 2025 were 570.1M, a 16.29% decrease year-over-year.
- BridgeBio Pharma, Inc. cash on hand for 2025 were 570.1M, a 16.29% decrease from 2024.
- BridgeBio Pharma, Inc. cash on hand for 2024 were 681.1M, a 81.18% increase from 2023.
- BridgeBio Pharma, Inc. cash on hand for 2023 were 375.9M, a 0.20% decrease from 2022.
- BridgeBio Pharma, Inc. cash on hand for 2022 were 376.7M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| BridgeBio Pharma, Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $570 |
| 2024 | $681 |
| 2023 | $376 |
| 2022 | $377 |
| 2021 | $394 |
| 2020 | $356 |
| 2019 | $364 |
| BridgeBio Pharma, Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2025-12-31 | $570 |
| 2024-12-31 | $681 |
| 2023-12-31 | $376 |
| 2022-12-31 | $377 |
| 2021-12-31 | $394 |
| 2020-12-31 | $356 |
| 2019-12-31 | $364 |
BridgeBio Pharma, Inc. Cash on Hand — FAQ
BridgeBio Pharma, Inc. (BBIO) cash on hand over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BBIO's cash on hand history?
The chart and table above show BridgeBio Pharma, Inc.'s cash on hand by year and by quarter, including the growth rate.